Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28th.
SALT LAKE CITY (PRWEB) MARCH 01, 2019
Neil Riordan, PA, PhD presented “Results From Panama Clinical Trials Using Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (HUCT-MSCs) for Multiple Sclerosis and Autism” at the 5th Annual Perinatal Stem Cell Society Congress in Salt Lake City, UT on Thursday, February 28t.
During his talk, Dr. Riordan discussed his recently published phase I/II clinical trial entitled, “Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis”.
“It was an honor to speak with my distinguished peers on the advances of stem cell therapy in perinatal medicine today,” Neil H. Riordan, PA, PhD
He also touched on his recently completed and soon-to-be-published phase 1/II clinical trial on autism, “Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism” (NCT02192749).
About Perinatal Stem Cell Society
In 2013, the International Perinatal Stem Cell Society, Inc. a non-profit (501(c)(3) organization was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many diseases and disorders. Perinatal stem cell sources include: amnion, amniotic fluid, cord blood, cord tissue/wharton’s jelly, as well as placental blood and placental tissue. Perinatal stem cells are formed around the time of birth and are classified as adult stem cells but they really are more primitive then stem cells found in bone marrow or adipose tissue or other traditional sources of adult stem cells and as such, have greater therapeutic potential.
Learn more at http://www.perinatalstemcells.com
About Riordan Technologies
Riordan Technologies strives to improve the human condition through innovation in scientific research, regenerative medicine, and stem cell therapy. Riordan Technologies comprises companies founded by Neil Riordan, PA, PhD: Dallas-based Aidan Products, Signature Biologics, and Riordan Medical Institute, and Panama-based Stem Cell Institute and Medistem Panama.
Read Dr. Riordan’s Amazon #1 Best Seller: Stem Cell Therapy: A Rising Tide – How Stem Cells Are Disrupting Medicine and Transforming Lives
Learn more at at http://www.neilriordan.com